Grants And Prizes

Hamblin Prize

The Hamblin Prize was established in 2008 in honour of Professor Terry Hamblin, the founder of the UK CLL Forum. Given his major contributions to the CLL literature, both as author and editor, it was felt that this prize should be awarded for the best CLL-related publication from a UK-based group in the previous year.

2008 - Dr Andrea Buggins, Kings College London for her paper "Tumor-derived IL-6 may contribute to the immunological defect in CLL. Leukaemia, Epub Nov 12007

2009 - Gillian G. Johnson for her article 'A Novel Type of p53 Pathway Dysfunction in Chronic Lymphocytic Leukemia Resulting from Two Interacting Single Nucleotide Polymorphisms within the p21 Gene'. Published in Cancer Research 2009; 69:(12). June 15

2013 - Professor Andrew Pettitt for his paper 'Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial.' Published in J Clin Oncol. 2012;30(14):1647-55

2014 - Ruth Clifford, for her paper ‘SAMHD1is mutated recurrently in CLL and is involved in response to DNA damage' Blood.2014 Feb 13;123(7):1021-31

The annual Catovsky prize (£500) was established in 2006 by the UK CLL Forum in recognition of the outstanding contribution that Professor Daniel Catovsky has made to the field of clinical and scientific CLL research. All non-tenured CLL researchers are invited to submit an abstract of their research work for consideration by the UK CLL Forum Executive committee. The four highest scoring abstracts are selected for 15 minute oral presentation at the annual educational meeting. A panel then selects the winning applicant based on these presentations.

2012 - Emilio Cosimo, Institue of Cancer Studies, College of Medicine, Veterinary and Life Sciences, University of Glasgow.

2013 - Best Oral Presentation. Elizabeth WalsbyUniversity of Cardiff for her paper 'Migration of primary CLL cells across the vascular endothelium modeled and characterised in a novel in vitro circulation system'.

2013 - Best Poster Presentation Elinor Chapman from the Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool for her poster entitled 'The AKT inhibitor AZD5363 inhibits the proliferation of chronic lymohocytic leukaemia cells and revers chemo-resistance induced by stromal interactions'

This website is still being developed, and we would be delighted to receive suggestions for content and improvement, notification of corrections etc at cll@hartleytaylor.co.uk. UK Registered Charity No. 1104229